Oligonucleotide therapies are among the most promising biological therapeutics. They target disease at a different stage of ...

AlphaFold, an AI tool, predicts protein structure from amino acid sequences. MIT researchers, led by Professor Richard Young, have developed ProtGPS, a model that predicts where proteins localize ...

Using a series of more than 1,000 X-ray snapshots of the shapeshifting of enzymes in action, researchers at Stanford ...

As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

A team from the University of Washington led by Nobel laureate David Baker is using artificial intelligence to design ...

Using a new animal model of Alzheimer’s disease, the study highlights a potential breakthrough in treatment strategies.

New research uses AI to engineer enzymes with intricate active sites, expanding the possibilities for synthetic biocatalysts.

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

Enzymes significantly speed up the chemical reactions that keep you alive. Researchers are using AI to create new ones to tackle modern challenges.

A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the German Cancer Research Center (DKFZ), the Hector Institute für Translational ...

Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...